Sarepta CEO Douglas Ingram to retire by end of 2026

Douglas Ingram will retire as Sarepta CEO by late 2026 after a year of safety issues and job cuts. The company is now searching for his replacement.

Xurve View
洞察:

Sarepta Therapeutics, Inc. has announced that Chief Executive Officer Douglas Ingram will retire by the end of 2026 or upon the appointment of a successor. The company has initiated a formal search for his replacement, according to a recent regulatory filing. Ingram has served as the head of the firm since 2017.

The corporate signage for Sarepta Therapeutics is displayed at their Cambridge, Massachusetts location in the United States, captured on July 22, 2025. REUTERS/Brian Snyder
IUX24

IUX24 提供深度財經、經濟與投資資訊,藉助 AI 發掘全球市場中最重要的信號。

IFZA Properties, Dubai Silicon Oasis, DSO-IFZA, Dubai, United Arab Emirates

Copyright IUX24 MEDIA - FZCO. 版權所有。

由 AI 驅動 • 精益求精

IUX24 是一個資訊與分析平台,提供新聞、市場數據、分析工具及 AI 驅動的功能,僅供資訊參考與教育用途。所提供的服務和資訊不構成投資建議、交易信號或經紀服務。投資涉及風險,用戶在作出投資決定前應審慎評估相關資訊。